Adamas Pharmaceuticals (ADMS) News Today → Biden replacement revealed? (From Paradigm Press) (Ad) Free ADMS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSurvalent, Electroval win bid to provide ICE "first of its kind" ADMS and DERMS platformbenzinga.com - April 7 at 8:45 PMAdvanced Distribution Management Systems (ADMS) Market 2023 | Global Industry Report Forecast 2029marketwatch.com - April 7 at 8:45 PMAdvanced Distribution Management Systems (ADMS) Market LATEST REPORT 2023 to 2030marketwatch.com - March 30 at 12:32 AMAdamas One Corp (JEWL)investing.com - March 3 at 1:09 AM2023 Advanced Distribution Management System (ADMS) Market: Top Growing Regions for Business Leaders by 2029marketwatch.com - March 1 at 10:57 AMAdvanced Distribution Management System (ADMS) Market 2023 | Global Industry Report Forecast 2029marketwatch.com - March 1 at 10:57 AMAdvanced Distributed Management System (ADMS) Market Is Booming Worldwide Forecast 2023-2029marketwatch.com - February 24 at 9:19 AMAdvanced Distribution Management Systems (ADMS) Market Future Trends Demand 2023, and Forecast to 2029marketwatch.com - January 14 at 12:06 AM8 Stocks to Buy According to Devesh Gandhi’s SilverArc Capitalinsidermonkey.com - May 25 at 5:07 AMSupernus Pharmaceuticals Completes Acquisition of Adamas Pharmaceuticalsfinance.yahoo.com - November 24 at 1:41 PMmarketbeat.com - November 24 at 6:03 AMSupernus Pharmaceuticals, inc (SUPN) Q3 2021 Earnings Call Transcriptfinance.yahoo.com - November 4 at 12:30 AMHow Much Of Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) Do Institutions Own?finance.yahoo.com - November 2 at 8:26 AMEast Bay drug maker's potential sale brings lawsuits, job cutsbizjournals.com - November 1 at 12:23 PMWill Adamas Pharmaceuticals (ADMS) Report Negative Q3 Earnings? What You Should Knowfinance.yahoo.com - October 28 at 6:22 PMADAMAS ALERT: Bragar Eagel & Squire, P.C. Announces Commencement of Tender Offer and Encourages Investors to Contact the Firmfinance.yahoo.com - October 27 at 5:19 PMWhy Supernus' Acquisition of Adamas Is a Smart Movefinance.yahoo.com - October 21 at 8:59 AMSHAREHOLDER ALERT: WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its Ongoing Investigationsfinance.yahoo.com - October 18 at 6:13 PMSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADMS, AZPN, GSKY, GWB; Shareholders are Encouraged to Contact the Firmfinance.yahoo.com - October 18 at 1:02 PMSHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Adamas Pharmaceuticals, Inc. - ADMSprnewswire.com - October 16 at 12:30 AMSHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Adamas Pharmaceuticals, Inc. - ADMSfinance.yahoo.com - October 15 at 11:46 PMADAMAS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of ADMS and Encourages Investors to Contact the Firmfinance.yahoo.com - October 14 at 8:04 PMADAMAS PHARMACEUTICALS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adamas ...businesswire.com - October 13 at 12:21 AMSHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Adamas Pharmaceuticals, Inc. Mergerfinance.yahoo.com - October 12 at 2:15 PMSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADMS, FLXN, AZPN, CXP; Shareholders are Encouraged to Contact the Firmfinance.yahoo.com - October 12 at 2:15 PMAdamas Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Adamas Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to ...businesswire.com - October 11 at 10:40 PMSHAREHOLDER ALERT: WeissLaw LLP Investigates Adamas Pharmaceuticals, Inc.prnewswire.com - October 11 at 8:40 PMShareholder Alert: Ademi LLP investigates whether Adamas Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Supernusfinance.yahoo.com - October 11 at 5:39 PMSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of Adamas Pharmaceuticals, Inc. with Supernus Pharmaceuticals, Inc.finance.yahoo.com - October 11 at 5:39 PMMid-Day Market Update: Crude Oil Surges Over 2%; Supernus Pharmaceuticals To Acquire Adamas Pharmaceuticalsmarkets.businessinsider.com - October 11 at 12:39 PMSupernus bolsters Parkinson's portfolio with $400 mln deal for Adamas Pharmareuters.com - October 11 at 12:39 PMADMS Stock Soars 70% Thanks to Adamas Pharmaceuticals Acquisition Newsmsn.com - October 11 at 12:39 PMUPDATE 3-Supernus bolsters Parkinson's portfolio with $400 mln deal for Adamas Pharmafinance.yahoo.com - October 11 at 12:39 PMAdamas Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Adamas Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ADMSfinance.yahoo.com - October 11 at 12:39 PMFlexion and Adamas Surge. The Small-Cap Pharma Firms Are Being Acquired.finance.yahoo.com - October 11 at 12:39 PMUPDATE 1-Supernus to buy Adamas Pharma for about $400 mlnmsn.com - October 11 at 7:39 AMSupernus Pharma To Acquire Adamas Pharma For Total Consideration Up To $9.10/shrnasdaq.com - October 11 at 7:39 AMSupernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfoliofinance.yahoo.com - October 11 at 7:39 AMAdamas Named 2021 Finalist in the New Therapeutics Category of the UCSF Health Awardsfinance.yahoo.com - October 1 at 1:38 PMAdamas Announces GOCOVRI Presentations at the Upcoming International Parkinson and Movement Disorder Society's (MDS) Congressstockhouse.com - September 18 at 12:29 AMAdamas Announces GOCOVRI Presentations at the Upcoming International Parkinson and Movement Disorder Society’s (MDS) Congressfinance.yahoo.com - September 16 at 2:58 PMAdamas Announces New Employment Inducement Grantsfinance.yahoo.com - September 10 at 9:06 PMLooking Into Adamas Pharmaceuticals's Return On Capital Employedbenzinga.com - September 10 at 4:03 PMAdamas to Present at Upcoming September Investor Conferencesfinance.yahoo.com - August 30 at 5:03 PMAdamas Pharmaceuticals Inc (ADMS) Q2 2021 Earnings Call Transcriptfinance.yahoo.com - August 10 at 12:08 AMAdamas Pharmaceuticals earnings preview: what Wall Street is expectingmarkets.businessinsider.com - August 9 at 7:07 PMAdamas Pharmaceuticals (ADMS) Reports Q2 Loss, Lags Revenue Estimatesnasdaq.com - August 9 at 7:07 PMAdamas Reports Second Quarter 2021 Financial Resultsfinance.yahoo.com - August 9 at 7:07 PMAdamas Pharmaceuticals Inc hosts conference call for investorsmarkets.businessinsider.com - August 5 at 9:39 AMAdamas to Announce Second Quarter Financial Results and Host Conference Call on August 9, 2021finance.yahoo.com - August 2 at 5:39 PM Get Adamas Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ADMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13. See his shocking evidence in this new report ADMS Media Mentions By Week ADMS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADMS News Sentiment▼0.000.34▲Average Medical News Sentiment ADMS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADMS Articles This Week▼00▲ADMS Articles Average Week Get Adamas Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ADMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NKTX News PEPG News ANRO News NATR News RVNC News HROW News HRTX News MRSN News AMRN News FBLG News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADMS) was last updated on 5/1/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPubYour bank is lying to you.MyBankTracker#1 election stockPorter & CompanyBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingBiden out June 13; Kamala won’t replace him?Paradigm Press4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adamas Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
